Intrexon taps new COO, CBO in executive reshuffle; Denali targets up to $182M in IPO
→ Another round of leadership changes is taking place at Intrexon $XON: retired lieutenant general Thomas Bostick is slated to replace COO Andrew Last; Teva vet Nir Nimrodi has been promoted as chief business officer; and Helen Sabzevari is taking the helm of Precigen as president of the subsidiary. This marks the latest move by hands-on billionaire backer and CEO Randal “RJ” Kirk, after the high profile departure of then-president Gene Germano in March. “A more streamlined senior management structure is in line with our transition to a group of related and increasingly commercially oriented enterprises,” Kirk said in a statement.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.